CVS Health Corporation $CVS Shares Sold by Sumitomo Mitsui Trust Group Inc.

Sumitomo Mitsui Trust Group Inc. cut its holdings in shares of CVS Health Corporation (NYSE:CVS) by 2.0% in the third quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 2,830,609 shares of the pharmacy operator’s stock after selling 58,275 shares during the quarter. Sumitomo Mitsui Trust Group Inc.’s holdings in CVS Health were worth $242,555,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently bought and sold shares of the company. Kilter Group LLC acquired a new position in shares of CVS Health in the second quarter worth $27,000. J.Safra Asset Management Corp acquired a new stake in CVS Health during the second quarter valued at $30,000. Beaird Harris Wealth Management LLC boosted its position in CVS Health by 201.0% during the second quarter. Beaird Harris Wealth Management LLC now owns 292 shares of the pharmacy operator’s stock valued at $30,000 after purchasing an additional 195 shares during the last quarter. Timbuktu Capital Management LLC acquired a new stake in CVS Health during the second quarter valued at $31,000. Finally, Dunhill Financial LLC purchased a new position in CVS Health in the second quarter valued at about $32,000. Hedge funds and other institutional investors own 80.66% of the company’s stock.

CVS Health News Summary

Here are the key news stories impacting CVS Health this week:

• Positive Sentiment: One valuation analysis says CVS could be approximately 27% undervalued, with the next earnings report providing a potential catalyst. Analysts reportedly expect quarterly earnings of about $1.62 per share, making segment performance and management commentary important for the shares. CVS Health Could Be 27% Undervalued As Earnings Focus Sharpens
• Positive Sentiment: CVS’s free Project Health screenings, which do not require appointments or insurance, support the company’s community-health strategy and could strengthen patient engagement and brand visibility. The immediate financial impact is likely limited. CVS Health Project Health Screenings
• Neutral Sentiment: Articles highlight CVS’s broader strategy of combining healthcare services with housing and other social-support initiatives. The approach may improve long-term outcomes and customer retention, but near-term earnings effects are unclear. CVS Health Beyond Housing
• Neutral Sentiment: Analyst-estimate and ratings coverage provides context ahead of earnings but does not identify a clear change in consensus or a new company-specific catalyst. CVS Health Stock Analyst Estimates and Ratings
• Negative Sentiment: The University of Kentucky and five other hospital systems are suing CVS over alleged fraud or prescription-contract breaches. The claims, including a reported $41 million UK lawsuit, create litigation, reimbursement, and reputational risks, although the allegations have not been proven. Hospital Systems Sue CVS UK Sues CVS Health
• Negative Sentiment: CVS reportedly faces as much as $2 billion of Medicare ratings-related risk. Any reduction in Medicare Advantage star ratings could hurt bonus payments, membership economics, and expectations for future earnings. CVS Health Medicare Ratings Risk

CVS Health Trading Down 0.1%

CVS Health stock opened at $90.20 on Monday. The business has a 50 day moving average price of $91.22 and a two-hundred day moving average price of $88.76. The company has a quick ratio of 0.66, a current ratio of 0.87 and a debt-to-equity ratio of 0.74. The stock has a market cap of $115.36 billion, a price-to-earnings ratio of 23.86, a price-to-earnings-growth ratio of 0.84 and a beta of 0.58. CVS Health Corporation has a 12 month low of $69.51 and a 12 month high of $110.68.

CVS Health (NYSE:CVS) last announced its quarterly earnings results on Wednesday, August 5th. The pharmacy operator reported $2.58 EPS for the quarter, topping analysts’ consensus estimates of $1.87 by $0.71. CVS Health had a net margin of 1.18% and a return on equity of 13.12%. The firm had revenue of $106.10 billion during the quarter, compared to analysts’ expectations of $100.03 billion. During the same quarter last year, the company earned $1.81 earnings per share. The company’s revenue for the quarter was up 7.3% compared to the same quarter last year. CVS Health has set its FY 2026 guidance at 7.900-8.100 EPS. As a group, equities analysts forecast that CVS Health Corporation will post 8.02 EPS for the current year.

CVS Health Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, November 2nd. Shareholders of record on Thursday, October 22nd will be given a $0.6650 dividend. The ex-dividend date is Thursday, October 22nd. This represents a $2.66 annualized dividend and a yield of 2.9%. CVS Health’s payout ratio is presently 70.37%.

Wall Street Analysts Forecast Growth

Several equities research analysts recently commented on the company. Argus boosted their price target on CVS Health from $104.00 to $114.00 and gave the company a “buy” rating in a research note on Wednesday, August 19th. HSBC reaffirmed a “hold” rating and set a $103.00 price objective on shares of CVS Health in a research report on Monday, July 6th. Cantor Fitzgerald reaffirmed a “neutral” rating on shares of CVS Health in a research report on Friday, October 9th. Wall Street Zen cut shares of CVS Health from a “strong-buy” rating to a “buy” rating in a research note on Monday, October 19th. Finally, Robert W. Baird set a $107.00 target price on shares of CVS Health in a research report on Thursday, August 6th. Nineteen analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $109.64.

About CVS Health

CVS Health Corporation (NYSE: CVS) is a diversified health care company that provides pharmacy, insurance and health services in the United States. Its businesses serve consumers, employers, health plans and health care providers through pharmacies, benefit programs, insurance coverage and clinical care services.

The company’s Pharmacy Services segment, led by CVS Caremark, manages prescription drug benefits for employers, insurers and government programs. CVS Pharmacy operates retail pharmacies and health-focused stores that dispense prescriptions and offer over-the-counter products, health and wellness merchandise, immunizations and related services.